Introducing new screens: Why are we all doing different things?

Summary The disease panels covered by newborn blood spot screening vary greatly from country to country. There are different interpretations of the Wilson and Jungner principles and of underlying data in the scientific literature, and great disparities between the value judgements applied in screeni...

Full description

Saved in:
Bibliographic Details
Published inJournal of inherited metabolic disease Vol. 30; no. 4; pp. 423 - 429
Main Author Pollitt, R. J.
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.08.2007
Blackwell Publishing Ltd
Subjects
Genetic Predisposition to Disease
Genetic Techniques
Health Policy
Humans
Infant, Newborn
Mass Spectrometry - methods
Metabolism, Inborn Errors - diagnosis
Metabolism, Inborn Errors - genetics
Neonatal Screening - methods
Sensitivity and Specificity
Online AccessGet full text

Cover

More Information
Summary:Summary The disease panels covered by newborn blood spot screening vary greatly from country to country. There are different interpretations of the Wilson and Jungner principles and of underlying data in the scientific literature, and great disparities between the value judgements applied in screening and in routine clinical practice.
Bibliography:Competing interests: None declared
Communicating editor: Georg Hoffmann
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0141-8955
1573-2665
DOI:10.1007/s10545-007-0647-2